Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter J Paulus

Circulation

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Circulation|November 2, 2020
Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection FractionJennifer E Ho, Margaret M Redfield, Gregory D Lewis, et al.
Circulation|February 9, 2005
Cardiomyocyte stiffness in diastolic heart failureAttila Borbély, Jolanda van der Velden, Zoltán Papp, et al.
Circulation|July 1, 2016
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan RoadmapSanjiv J Shah, Dalane W Kitzman, Barry A Borlaug, et al.
Circulation|April 19, 2006
Myocardial structure and function differ in systolic and diastolic heart failureLoek van Heerebeek, Attila Borbély, Hans W M Niessen, et al.
Circulation|May 12, 2010
Peripartum cardiomyopathy as a part of familial dilated cardiomyopathyKarin Y van Spaendonck-Zwarts, J Peter van Tintelen, Dirk J van Veldhuisen, et al.
Circulation|July 6, 2006
Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchangerR Arthur Bouwman, Kanita Salic, F Gieneke Padding, et al.
Circulation|August 17, 2011
Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffnessInês Falcão-Pires, Nazha Hamdani, Attila Borbély, et al.
Circulation|July 19, 2012
Low myocardial protein kinase G activity in heart failure with preserved ejection fractionLoek van Heerebeek, Nazha Hamdani, Inês Falcão-Pires, et al.
Circulation|April 8, 2009
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitusRutger W van der Meer, Luuk J Rijzewijk, Hugo W A M de Jong, et al.
Circulation|December 12, 2007
Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tensionLoek van Heerebeek, Nazha Hamdani, M Louis Handoko, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Circulation|November 2, 2020
Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection FractionJennifer E Ho, Margaret M Redfield, Gregory D Lewis, et al.
Circulation|February 9, 2005
Cardiomyocyte stiffness in diastolic heart failureAttila Borbély, Jolanda van der Velden, Zoltán Papp, et al.
Circulation|July 1, 2016
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan RoadmapSanjiv J Shah, Dalane W Kitzman, Barry A Borlaug, et al.
Circulation|April 19, 2006
Myocardial structure and function differ in systolic and diastolic heart failureLoek van Heerebeek, Attila Borbély, Hans W M Niessen, et al.
Circulation|May 12, 2010
Peripartum cardiomyopathy as a part of familial dilated cardiomyopathyKarin Y van Spaendonck-Zwarts, J Peter van Tintelen, Dirk J van Veldhuisen, et al.
Circulation|July 6, 2006
Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchangerR Arthur Bouwman, Kanita Salic, F Gieneke Padding, et al.
Circulation|August 17, 2011
Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffnessInês Falcão-Pires, Nazha Hamdani, Attila Borbély, et al.
Circulation|July 19, 2012
Low myocardial protein kinase G activity in heart failure with preserved ejection fractionLoek van Heerebeek, Nazha Hamdani, Inês Falcão-Pires, et al.
Circulation|April 8, 2009
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitusRutger W van der Meer, Luuk J Rijzewijk, Hugo W A M de Jong, et al.
Circulation|December 12, 2007
Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tensionLoek van Heerebeek, Nazha Hamdani, M Louis Handoko, et al.
Pageof 2